Pharmaceutical Executive-11-01-2016

Pharmaceutical Executive

Pharm Exec's 2017 Pipeline Report

December 07, 2016

Features

36

11

The industry is readying for a leap into a new age of complex therapies, as new heights are reached in fields such as regenerative cell-based therapies, CAR-T and immuno-oncology combinations. Elaborate manufacturing and soaring drug costs, however, loom as deep chasms to cross in bridging the potential with reality.

Building Market Access Competencies for the Future

November 11, 2016

Features

36

11

An industry-based working group presents a common standards and definition framework for “Access” competencies in pharma-as a starting point in solving the current shortage of talent and leaders for this widening set of activities.

Flipping the Generics Map: Apotex's Jeremy Desai

November 09, 2016

Features

36

11

Pharm Exec sits down with Jeremy Desai, CEO of Apotex, Canada’s largest producer of generic drugs, to discuss the local impact of mounting pricing pressure-and how smaller and independent companies can survive in an era of consolidation and growing competition.

The Cancer Care Conundrum in Europe

November 01, 2016

Columns

36

11

Cancer treatment is an increasing dilemma for EU health services as they try to balance patient care against budgetary constraints.

Has Gastein Peaked?

November 01, 2016

Columns

36

11

This year’s 19th annual European Health Forum Gastein (Austria) once again attempted to establish unity in the face of EU woes. But are the Gastein region’s “healing powers” on the wane?

Country Report: Switzerland

November 01, 2016

Special Sponsored Section

36

11

Switzerland’s formidable pedigree as a pharmaceuticals powerhouse and hotbed of scientific innovation is often overlooked. But indeed these elements serve as major linchpins of the Swiss national economy, as the country continues to punch above its weight on the global stage for health affairs and medical-science advancement.

Pharmaceutical Executive, November 2016 Issue (PDF)

November 01, 2016

Issue PDF

36

11

Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.